Correction to: Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial - Summary - MDSpire
Advertisement
Correction to: Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial
To correct inaccuracies in the original publication regarding axillary surgery and its implications in T1N0 breast cancer, specifically addressing the misinterpretation of results.
Key Findings:
The role of axillary surgery has evolved to a staging method with the adoption of sentinel lymph node biopsy.
The incidence of distant metastases among patients with axillary recurrence reflects the aggressive biology of the primary tumor.
Patients with axillary recurrence and distant metastases may represent a biologically aggressive subgroup with a poorer prognosis.
Interpretation:
The corrections clarify the implications of axillary surgery and the biological behavior of breast cancer in the context of distant metastases.
Limitations:
The erratum does not address any potential limitations of the original study design or methodology, which should be acknowledged.
Conclusion:
The amendments provide a clearer understanding of the relationship between axillary recurrence and distant metastases in breast cancer, highlighting the need for further research.